En español
NIDA

NIH launches landmark study on substance use and adolescent brain development

Thirteen grants awarded to look at cognitive and social development in ~10,000 children

September 25, 2015

The National Institutes of Health today awarded 13 grants to research institutions around the country as part of a landmark study about the effects of adolescent substance use on the developing brain. The Adolescent Brain Cognitive Development (ABCD) Study will follow approximately 10,000 children beginning at ages 9 to10, before they initiate drug use, through the period of highest risk for substance use and other mental health disorders. Scientists will track exposure to substances (including nicotine, alcohol, and marijuana), academic achievement, cognitive skills, mental health, and brain structure and function using advanced research methods.

ABCD logo - brains at various levels of development according to age

"With advances in neuroimaging and other investigative tools, we will be able to look in greater detail at the impact of substance use on young people," said Nora D. Volkow, M.D., director of NIH’s National Institute on Drug Abuse (NIDA). "Adolescents have access to high potency marijuana and greater varieties of nicotine delivery devices than previous generations. We want to know how that and other trends affect the trajectory of the developing brain."

"The ABCD Study is an important opportunity to closely examine, in humans, the hypothesized link between adolescent alcohol abuse and long-term harmful effects on brain development and function," said George Koob, Ph.D., director of NIH’s National Institute on Alcohol Abuse and Alcoholism (NIAAA). "Recent human studies have revealed an acceleration in the typical decline in volume of neocortical areas and smaller increases in white matter volume in adolescents who transitioned to heavy drinking compared to those who did not using magnetic resonance imaging."

The ABCD Study will seek to address many questions related to substance use and development that will help inform prevention and treatment research priorities, public health strategies, and policy decisions, including:

  • What is the impact of occasional versus regular use of marijuana, alcohol, tobacco, and other substances, alone or in combination, on the structure and function of the developing brain?
  • How does the use of specific substances impact the risk for using other substances?
  • What are the brain pathways that link adolescent substance use and risk for mental illnesses?
  • What impact does substance use have on physical health, psychological development, information processing, learning and memory, academic achievement, social development, and other behaviors?
  • What factors (such as prenatal exposure, genetics, head trauma, and demographics) influence the development of substance use and its consequences?

The 13 grants issued today (attached) will fund a Coordinating Center, a Data Analysis and Informatics Center, and 11 research project sites. The requests for applications and other information about the ABCD Study, including protection of patient confidentiality and parental consent, can be found at http://addictionresearch.nih.gov/adolescent-brain-cognitive-development-study. The ABCD Study was initiated by the Collaborative Research on Addiction at NIH (CRAN), a consortium of institutes that include a focus on addiction research. CRAN is comprised of NIDA, NIAAA and the National Cancer Institute. Other NIH collaborators in this project are the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Mental Health, the National Institute on Minority Health and Health Disparities, the National Institute of Neurological Disorders and Stroke; and the Office of Behavioral and Social Sciences Research.

NIDA has a special section on its website related to the current state of the science on substances and brain health. 


ABCD Awardees are listed below:

Coordinating Center:
Terry L. Jernigan, Ph.D., University of California, San Diego  
Sandra A. Brown, Ph.D., University of California, San Diego

Data Analysis and Informatics Center:
Anders M. Dale, Ph.D., University of California, San Diego

Research Project Sites:

  1. Betty J. Casey, Ph.D., Weill Medical College of Cornell University
    Rita Z. Goldstein, Ph.D., Icahn School of Medicine at Mount Sinai
  2. Duncan B. Clark, M.D., Ph.D., University of Pittsburgh  
  3. Ian M. Colrain, Ph.D., SRI International      
  4. Thomas M. Ernst, Ph.D., University of Hawaii at Manoa
    George Fein, Ph.D., Neurobehavioral Research, Inc., Wailuku              
    Thomas A. Wills, Ph.D., University of Hawaii at Manoa
  5. Raul Gonzalez, Ph.D., Florida International University  
  6. Mary M. Heitzeg, Ph.D., University of Michigan
    Linda B. Cottler, Ph.D., M.P.H., University of Florida
    Sara Jo Nixon, Ph.D., University of Florida
    Robert A. Zucker, Ph.D., A.B.P.P., University of Michigan
  7. William G. Iacono, Ph.D., University of Minnesota
    Marie T. Banich, Ph.D., University of Colorado
    Deanna M. Barch, Ph.D., Washington University, St. Louis
    James M. Bjork, Ph.D., Virginia Commonwealth University
    Andrew C. Heath, D.Phil. Washington University, St. Louis
    Monica M. Luciana, Ph.D., University of Minnesota
    Pamela A. Madden, Ph.D., Washington University, St. Louis
    Michael C. Neale Ph.D., Virginia Commonwealth University           
  8. Bonnie J. Nagel, Ph.D., Oregon Health & Science University 
    Damien A. Fair, Oregon Health & Science University 
    Sarah W. Feldstein Ewing, Ph.D., Oregon Health & Science University
    Hugh P. Garavan, Ph.D., University of Vermont
  9. Elizabeth R. Sowell, Ph.D., Children's Hospital of Los Angeles
    Susan Y. Bookheimer, Ph.D., University of California, Los Angeles 
  10. Susan F. Tapert, Ph.D., University of California, San Diego
    Martin P. Paulus, M.D., Laureate Institute for Brain Research, Tulsa
  11. Deborah A. Yurgelun-Todd, Ph.D., University of Utah
    Perry F. Renshaw, M.D., Ph.D., University of Utah

Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institute on Alcohol Abuse and Alcoholism (NIAAA): The National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health, is the primary U.S. agency for conducting and supporting research on the causes, consequences, prevention, and treatment of alcohol abuse, alcoholism, and alcohol problems. NIAAA also disseminates research findings to general, professional, and academic audiences. Additional alcohol research information and publications are available at www.niaaa.nih.gov.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

This page was last updated September 2015

News Releases

Sep 2016

Aug 2016

Jul 2016

Jun 2016

May 2016

Apr 2016

Mar 2016

Feb 2016

Jan 2016

Dec 2015

Nov 2015

Oct 2015

Sep 2015

Aug 2015

Jul 2015

Jun 2015

May 2015

Apr 2015

Mar 2015

Feb 2015

Jan 2015

Dec 2014

Nov 2014

Oct 2014

Sep 2014

Aug 2014

Jul 2014

Jun 2014

May 2014

Apr 2014

Mar 2014

Feb 2014

Jan 2014

Dec 2013

Nov 2013

Oct 2013

Sep 2013

Aug 2013

Jul 2013

Jun 2013

May 2013

Apr 2013

Mar 2013

Feb 2013

Jan 2013

Dec 2012

Nov 2012

Oct 2012

Sep 2012

Aug 2012

Jul 2012

Jun 2012

May 2012

Apr 2012

Mar 2012

Feb 2012

Jan 2012

Dec 2011

Nov 2011

Oct 2011

Sep 2011

Aug 2011

Jul 2011

Jun 2011

May 2011

Apr 2011

Mar 2011

Jan 2011

Dec 2010

Nov 2010

Sep 2010

Aug 2010

Jul 2010

May 2010

Apr 2010

Mar 2010

Jan 2010

Get this Publication

Cite this article

APA style citation

National Institute on Drug Abuse. NIH launches landmark study on substance use and adolescent brain development Retrieved from https://www.drugabuse.gov/news-events/news-releases/2015/09/nih-launches-landmark-study-substance-use-adolescent-brain-development

press ctrl+c to copy
Receive Latest Science Articles in your Email!
You will only receive messages related to Latest Science